联邦贸易委员会起诉领先的跨性别健康组织WPATH，指控其欺骗性声明
Read, Watch or Listen
The U.S. Federal Trade Commission has filed a federal lawsuit against the World Professional Association for Transgender Health (WPATH), alleging deceptive marketing of pediatric gender-affirming medical interventions. Coordinating with attorneys general from Alaska, Iowa, Nebraska, and Texas, the FTC claims WPATH promoted puberty blockers, cross-sex hormones, and irreversible surgeries for minors as safe and medically necessary without adequate scientific support. The complaint, filed on June 17, 2026, further alleges WPATH failed to disclose serious, potentially permanent risks including infertility and loss of sexual function. The case marks a notable expansion of FTC consumer protection authority into medical guidelines and standards of care.
Prepared by Emily Rhodes and reviewed by editorial team.
Timeline of Events
- 历史上，FTC 旨在打击商业消费者欺诈
- 历史上，FTC 执法打击虚假广告
- 历史上，WPATH 制定跨性别健康指南
- 2026 年 6 月 17 日 FTC 提起联邦诉讼
- 2026 年 6 月 17 日四名州总检察长加入
- 2026 年 6 月 17 日诉状指控存在欺骗性医疗营销
- 2026 年 6 月 17 日诉讼援引未披露的永久性治疗风险
- 诉讼提起后，此案标志着对医疗保健的监督范围扩大
Why This Matters to You
这场诉讼影响着医疗保健和家庭。它质疑对跨性别未成年人某些治疗的安全性和必要性。如果您是家长，这提醒您要与医生一起研究并讨论潜在的风险。
The Bottom Line
美国联邦贸易委员会（FTC）正介入医疗监管，针对 WPATH（跨性别者健康专业人士协会）涉嫌欺骗性营销的行为。此案可能重新定义医疗护理标准和消费者保护。如果您认识正在为孩子寻求跨性别健康护理的人，值得转发。
- Articles Published:
- 1
- Right Leaning:
- 0
- Left Leaning:
- 0
- Neutral:
- 1
- Distribution:
- Left 0%, Center 100%, Right 0%
未在源文件中指定
未在源中指定。
Coverage of Story:
From Left
No left-leaning sources found for this story.
From Right
No right-leaning sources found for this story.
Comments